刘先娣△,谢丹.乳腺癌时辰化疗的临床疗效观察[J].实用中西医结合临床,2016,16(9): |
乳腺癌时辰化疗的临床疗效观察 |
Clinial observation on meridian lingers chemotherapy for breast cancer |
投稿时间:2016-03-12 修订日期:2016-06-12 |
DOI: |
中文关键词: 乳腺癌 时辰化疗 腋窝淋巴结 临床疗效 |
英文关键词: breast cancer neoadjuvant chemotherapy axillary lymph node chemotherapy curative effect. |
基金项目: |
|
摘要点击次数: 737 |
全文下载次数: 375 |
中文摘要: |
目的:观察乳腺癌新辅助时辰化疗疗效、副作用发生率情况。方法:对53例乳腺癌患者随机分到实验组(丑时新辅助化疗)、对照组(日常化疗组),比较两组疗效及副作用发生率。结果:两组总有效率(CR PR)上差异存在统计学意义(P<0.05),对照组中乳房原发肿瘤疗效、腋窝转移淋巴结缓解程度不一致(P<0.05)。两组在减少白细胞减少上发生率相当(P>0.05)、时辰化疗组恶心呕吐发生率较低(P<0.05)。结论:本研究提示夜间丑时行TEC化疗在治疗乳腺癌中较常规化疗能显著提高疗效,并且毒副反应小,安全可靠。 |
英文摘要: |
Objective: 0bserving on meridian lingers chemotherapy for breast cancer, to study the change of chemotherapy curative effect.Method:53 patients were randomly assignead to normal chemotherapy,and meridian lingers chemotherapy,to assess the equivalentity of chemotherapy curative effect on both of them.Results: Compring the RR(CR PR) of meridian lingers chemotherapy on the primary tumor and axillary lymph nodes with the normal chemotherapy ,there is statistical significance(P<0.05). In addition,Primary Tumors incline to much more sensitive to the chemotherapy than transfer of axillary lymph nodes(P<0.05)in the control group. A statistically significant appears on the nausea and vomiting in between two sets (P<0.05),while the leucocytes decreasing is negative(P>0.05).Conclusions: This study suggests that both of the breast cancer tumor and axillary lymph node are smaller and down-staging than before the neoadjuvant chemotherapy,and the meridian lingers chemotherapy has more advantage than the normal chemotherapy with a significantly improving the curative effects and little side effects. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |